Article
Increased N-terminal cleavage of alpha-2-antiplasmin in patients with liver cirrhosis.
Journal of thrombosis and haemostasis : JTH - 1 Nov 2013
Uitte de Willige S, Malfliet J J M C, Janssen H L A, Leebeek F W G, Rijken D C
Abstract excerpt
BACKGROUND: The activity of alpha-2-antiplasmin (α2AP), the main fibrinolytic inhibitor, is modified by N- and C-terminal proteolytic cleavages. C-terminal cleavage converts plasminogen-binding α2AP (PB-α2AP) into a non-plasminogen-binding derivative. N-terminal cleavage by antiplasmin-cleaving enzyme (APCE), a soluble, circulating derivative of fibroblast activation protein (FAP), turns native Met-α2AP into...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
